InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
33%
T+90 mean return
-7.0%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Zachary Jennifer, Directeur Juridique. Insider active across 2 companies, notably Merck & Co., Inc.. Cumulatively, 13 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €2m. History available since 4 May 2021. The latest transaction was filed on 27 January 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations13 total
25,423 shares@ US$97.9415.3% of flowCommon StockSEC:0001127602-25-002357:0
4,790 shares0Common StockSEC:0001562180-24-004656:0
19,417 shares@ US$87.1010.0% of flowCommon StockSEC:0001127602-24-003093:0
23,298 shares@ US$119.4316.4% of flowCommon StockSEC:0001127602-24-002026:0
3,486 shares0Common StockSEC:0001562180-23-004888:0
19,141 shares@ US$117.592313.1% of flowCommon StockSEC:0001127602-23-014759:0
75,436 shares@ US$56.0424.9% of flowCommon StockSEC:0001127602-23-003562:0
15,631 shares@ US$109.8810.2% of flowCommon StockSEC:0001127602-23-002228:0
68,367 shares0Common StockSEC:0001127602-22-024595:0
6,020 shares0Common StockSEC:0001562180-22-004883:0
18,420 shares@ US$73.510.0005% mcap76.6% of flowCommon StockSEC:0001127602-22-007033:0
5,772 sharesCommon StockSEC:0001127602-21-015758
5,772 shares@ US$75.980.0001% mcap23.4% of flowCommon StockSEC:0001127602-21-015758:0
13 of 13 declarations
About Zachary Jennifer
Jennifer Zachary is the Executive Vice President and General Counsel at Merck & Co., Inc. and REGENXBIO Inc. In this role, she oversees the legal and regulatory matters of the companies. Her expertise in business law is essential for risk management and compliance.
